Cargando…

QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor

Long-term neurocognitive difficulties in children treated for a brain tumor are well documented and known to be affected by treatment. However, longitudinal studies of these neurocognitive difficulties are scarce. In the present study, we investigated the impact of radiotherapy (RT) on the evolution...

Descripción completa

Detalles Bibliográficos
Autores principales: Bullens, Kristien, Sleurs, Charlotte, Van den Wyngaert, Linde, Vandenabeele, Karen, Vercruysse, Trui, Claeys, Laura, Prikken, Sofie, Jacobs, Sandra, Lemiere, Jurgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165026/
http://dx.doi.org/10.1093/neuonc/noac079.499
_version_ 1784720288082034688
author Bullens, Kristien
Sleurs, Charlotte
Van den Wyngaert, Linde
Vandenabeele, Karen
Vercruysse, Trui
Claeys, Laura
Prikken, Sofie
Jacobs, Sandra
Lemiere, Jurgen
author_facet Bullens, Kristien
Sleurs, Charlotte
Van den Wyngaert, Linde
Vandenabeele, Karen
Vercruysse, Trui
Claeys, Laura
Prikken, Sofie
Jacobs, Sandra
Lemiere, Jurgen
author_sort Bullens, Kristien
collection PubMed
description Long-term neurocognitive difficulties in children treated for a brain tumor are well documented and known to be affected by treatment. However, longitudinal studies of these neurocognitive difficulties are scarce. In the present study, we investigated the impact of radiotherapy (RT) on the evolution of neurocognition between different consecutive time points after diagnosis, and throughout treatment and survivorship. This study included 69 children diagnosed with a brain tumor at the University Hospitals Leuven who completed a comprehensive neuropsychological test battery (intelligence, memory, visuomotor functioning, and QoL) on at least three consecutive time points (2-year interval). Of all patients, 40 completed the test battery at 4 time points. The first assessment was conducted at the earliest possible moment after diagnosis and before the start of any adjuvant therapy. Mean age at diagnosis and first assessment were 7.75 and 7.92 years, respectively. The most common diagnoses were pilocytic astrocytoma (n=33) and medulloblastoma (n=11). 29.0% of the children received local RT and 15.9% received craniospinal RT. A repeated measures analysis with cranial irradiation (no, focal, craniospinal) as between-subjects factor and age at diagnosis as covariate demonstrated a significant interaction effect between time and type of irradiation for both overall intelligence (p=0.007) and QoL (p=0.006) for children with three and four assessments. Children who received craniospinal irradiation demonstrated a significant decline in overall intelligence and a significant worsening of QoL. For the non-irradiated group, an improvement of QoL was observed. For processing speed, a significant time effect was found for children with three and four assessments (p<0.001), with a significant improvement for the overall group. The results of this longitudinal study demonstrated diverse longitudinal trajectories. Children who received craniospinal irradiation are most often confronted with intellectual decline and worsening of QoL.
format Online
Article
Text
id pubmed-9165026
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91650262022-06-05 QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor Bullens, Kristien Sleurs, Charlotte Van den Wyngaert, Linde Vandenabeele, Karen Vercruysse, Trui Claeys, Laura Prikken, Sofie Jacobs, Sandra Lemiere, Jurgen Neuro Oncol Neuropsychology/Quality of Life Long-term neurocognitive difficulties in children treated for a brain tumor are well documented and known to be affected by treatment. However, longitudinal studies of these neurocognitive difficulties are scarce. In the present study, we investigated the impact of radiotherapy (RT) on the evolution of neurocognition between different consecutive time points after diagnosis, and throughout treatment and survivorship. This study included 69 children diagnosed with a brain tumor at the University Hospitals Leuven who completed a comprehensive neuropsychological test battery (intelligence, memory, visuomotor functioning, and QoL) on at least three consecutive time points (2-year interval). Of all patients, 40 completed the test battery at 4 time points. The first assessment was conducted at the earliest possible moment after diagnosis and before the start of any adjuvant therapy. Mean age at diagnosis and first assessment were 7.75 and 7.92 years, respectively. The most common diagnoses were pilocytic astrocytoma (n=33) and medulloblastoma (n=11). 29.0% of the children received local RT and 15.9% received craniospinal RT. A repeated measures analysis with cranial irradiation (no, focal, craniospinal) as between-subjects factor and age at diagnosis as covariate demonstrated a significant interaction effect between time and type of irradiation for both overall intelligence (p=0.007) and QoL (p=0.006) for children with three and four assessments. Children who received craniospinal irradiation demonstrated a significant decline in overall intelligence and a significant worsening of QoL. For the non-irradiated group, an improvement of QoL was observed. For processing speed, a significant time effect was found for children with three and four assessments (p<0.001), with a significant improvement for the overall group. The results of this longitudinal study demonstrated diverse longitudinal trajectories. Children who received craniospinal irradiation are most often confronted with intellectual decline and worsening of QoL. Oxford University Press 2022-06-03 /pmc/articles/PMC9165026/ http://dx.doi.org/10.1093/neuonc/noac079.499 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neuropsychology/Quality of Life
Bullens, Kristien
Sleurs, Charlotte
Van den Wyngaert, Linde
Vandenabeele, Karen
Vercruysse, Trui
Claeys, Laura
Prikken, Sofie
Jacobs, Sandra
Lemiere, Jurgen
QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor
title QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor
title_full QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor
title_fullStr QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor
title_full_unstemmed QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor
title_short QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor
title_sort qol-16. a 6-year longitudinal study of neurocognition in children treated for a brain tumor
topic Neuropsychology/Quality of Life
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165026/
http://dx.doi.org/10.1093/neuonc/noac079.499
work_keys_str_mv AT bullenskristien qol16a6yearlongitudinalstudyofneurocognitioninchildrentreatedforabraintumor
AT sleurscharlotte qol16a6yearlongitudinalstudyofneurocognitioninchildrentreatedforabraintumor
AT vandenwyngaertlinde qol16a6yearlongitudinalstudyofneurocognitioninchildrentreatedforabraintumor
AT vandenabeelekaren qol16a6yearlongitudinalstudyofneurocognitioninchildrentreatedforabraintumor
AT vercruyssetrui qol16a6yearlongitudinalstudyofneurocognitioninchildrentreatedforabraintumor
AT claeyslaura qol16a6yearlongitudinalstudyofneurocognitioninchildrentreatedforabraintumor
AT prikkensofie qol16a6yearlongitudinalstudyofneurocognitioninchildrentreatedforabraintumor
AT jacobssandra qol16a6yearlongitudinalstudyofneurocognitioninchildrentreatedforabraintumor
AT lemierejurgen qol16a6yearlongitudinalstudyofneurocognitioninchildrentreatedforabraintumor